EU-based drug development company

Life-changing therapies for unmet medical needs

BIO & MEDITECH

EXEQ worked with an EU-based biotech company specializing in gene therapy and drug development. With a diverse portfolio of drug products at various stages of development, the company is dedicated to addressing unmet medical needs and delivering transformative treatments to patients worldwide.

The client secured nearly €1M in grants, advancing drug development, accelerating market readiness for life-changing therapies, and benefiting from EXEQ’s support in grant administration.

Scope

  • Grant Strategy Development
  • Grant Writing and Reporting
  • Application Process
Challenge

Accelerating New Therapies with Targeted Funding

With a diverse portfolio of drug assets at various development stages, the company faced challenges navigating the complex landscape of national and EU grants. The key to success was identifying relevant opportunities for each project and creating a funding roadmap aligned with their priorities. A comprehensive strategy was essential to link their scientific and clinical objectives with grant requirements, necessitating tailored proposals to maximize funding success and accelerate therapy development.

Approach

Strategic Proposal Development to Advance Clinical Innovation

EXEQ developed tailored proposals for each asset, clearly articulating the scientific, clinical, and societal value of their therapies. This included highlighting each project’s strengths, addressing unmet medical needs, and aligning proposals with funding agencies’ priorities. We focused on structured narratives, robust data, and the healthcare impact of their innovations. By showcasing their assets effectively, we enhanced the competitiveness of their applications and supported clinical development progress.

Result & Impact

Securing Nearly €1M to Accelerate Life-Changing Therapies

During our 3-year collaboration, the client secured multiple grants, unlocking nearly €1M in funding from national and EU agencies. These resources advanced key drug candidates, strengthened investment in R&D, clinical trials, and regulatory processes, and accelerated the market path for life-changing therapies. The funding enhanced the client’s ability to address critical healthcare challenges and deliver innovative solutions. EXEQ managed project reporting and grant administration, ensuring compliance and streamlining development.

Could your project use some of our expertise to get funded?

Fill in the form